Nuropod Wearable Vagus Nerve Stimulation Device: Replacement Earpiece Available

Nuropod has made a standalone replacement earpiece available for its wearable vagus nerve stimulation device, giving users a compatible, personal-use part to continue structured daily sessions without replacing the device.

Sacramento, United States, October 26, 2026 /PressCable/ -- Nuropod has announced that its replacement earpiece, designed for the left ear and compatible only with the Nuropod port, is available to purchase separately for $50 through the company’s online store.

More information can be found at https://nuropod.com/products/earpiece

The move responds to how regularly the device is used. Nuropod reports more than 5 million user sessions, with most people wearing the device for around 30 minutes, once or twice a day. With the standalone replacement earpiece, the company seeks to address the wear that this level of use places on the part, letting users keep their routine without buying a full unit.

The replacement is made for individual use and should not be shared. It carries a six-month warranty, while the Nuropod device itself is covered for 24 months.

Nuropod is a wearable vagus nerve stimulation device that clips onto the tragus, the small flap of cartilage at the front of the ear. From there, it delivers gentle, controlled electrical pulses to the auricular branch of the vagus nerve using the proprietary AVNT™ (Auricular Vagal Neuromodulation Technology) waveform to support the nervous system.

As a non-invasive, FCC-compliant general wellness device, it needs no gel, prescription, or clinic visit, and it can be worn while working, reading, or watching television. More than 1,000 healthcare professionals work with the device, which is used alongside existing care rather than in place of it.

Nuropod’s underlying technology has been studied for effects on the autonomic nervous system, stress, sleep, focus, recovery, and overall nervous-system balance. It is supported by more than 60 completed clinical studies, with over 100 more underway, and has been tested in randomized, placebo-controlled research, making Nuropod the most studied wearable vagus nerve stimulation device.

That research base rests on more than 10 years of development and over $10 million invested in clinical work, carried out with more than 150 research partners. Studies are independently designed, led, and interpreted by outside investigators at partner institutions. Parasym, the research company behind Nuropod, provides the technology.

To order the replacement earpiece or learn more about Nuropod, visit https://nuropod.com

Disclaimer: Research referenced in this article was conducted using Parasym’s neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as guaranteed individual outcomes. Nuropod is classified by the FDA as a non-significant risk device and is not intended to diagnose, treat, cure, or prevent any disease.

Contact Info:
Name: PR Team
Email: Send Email
Organization: Nuropod by Parasym
Address: 2108 N Street, Sacramento, California 95816, United States
Website: https://nuropod.com/

Source: PressCable

Release ID: 89207434

Should any problems, inaccuracies, or doubts arise from the content contained within this press release, we kindly request that you inform us immediately by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and dependable information is at the core of our commitment to our readers.